$63.96
2.163.50%
At close: Jun 18, 5:00 PM EST
$63.92
-0.0353-0.06%
After Hours: Jun 18, 7:54 PM EST
Moderna Inc Earnings Estimates
MRNANASDAQ
Moderna Earnings Estimates, EPS & Revenue | NASDAQ:MRNA
Moderna (MRNA) is scheduled to report Q2 earnings on July 31, 2026. Analysts estimate EPS of $-2.07 and quarterly revenue of $104.40M.
In the most recent quarter (Q1), Moderna reported EPS of $-1.18, beating estimates of $-3.71 by 0.68%. Revenue came in at $389.00M, exceeding the estimate of $233.79M by 0.66%.
Moderna has beaten EPS estimates in 5 consecutive quarters.
Over the last 4 quarters, Moderna has averaged an EPS surprise of 0.48% and a revenue surprise of 0.27%.
Earnings Date
Jul 31
EPS Estimate
$-2.070
Quarterly Revenue Estimate
$104.40M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.20B
Moderna Earnings History
Analyze the earnings history of Moderna using advanced sorting and filters.
Loading calendar...
Moderna (MRNA) Earnings Per Share
The chart below shows Moderna's reported EPS compared to analyst estimates over recent quarters.
Moderna (MRNA) Revenue
The chart below shows Moderna's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Moderna (NASDAQ:MRNA) reporting earnings?
Moderna (MRNA) is scheduled to report earnings on July 31, 2026. The last reported earnings were for reported on May 1, 2026 for Q1.
What were the latest earnings per share (EPS) for Moderna (NASDAQ:MRNA)?
The Actual EPS was $-1.18, which beat the estimate of $-3.71.
What were Moderna’s (NASDAQ:MRNA) revenues?
The Actual Revenue was $389.00M, which beat the estimate of $233.79M.
